Page last updated: 2024-10-31

clorgyline and Neuralgia

clorgyline has been researched along with Neuralgia in 2 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.

Research Excerpts

ExcerptRelevanceReference
"Neuropathic pain is a serious chronic disorder caused by lesion or dysfunction in the nervous systems."1.36Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de ( Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, S1
Nakata, E1
Morita, A1
Mizuno, K1
Yamamura, K1
Kato, A1
Ohashi, K1
Villarinho, JG1
Oliveira, SM1
Silva, CR1
Cabreira, TN1
Ferreira, J1

Other Studies

2 other studies available for clorgyline and Neuralgia

ArticleYear
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
    Bioorganic & medicinal chemistry, 2010, Nov-01, Volume: 18, Issue:21

    Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes,

2010
Involvement of monoamine oxidase B on models of postoperative and neuropathic pain in mice.
    European journal of pharmacology, 2012, Sep-05, Volume: 690, Issue:1-3

    Topics: Animals; Clorgyline; Disease Models, Animal; Female; Mice; Monoamine Oxidase; Monoamine Oxidase Inhi

2012